Upsher-Smith Laboratories, LLC. has launched Klor-Con Powder (potassium chloride) for oral solution, 20 mEq. The company received approval of an abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for this product, which will be marketed and distributed by Upsher-Smith.
Sandoz, Inc. will continue as the licensed marketer and distributor in the U.S. for the balance of the Klor-Con line of potassium products.
The potassium chloride powder market had U.S. sales of approximately $98 million for the 12 months ending September, 2017, according to IMS Health.
“The past six months have been particularly exciting for Upsher-Smith as we have transitioned from a privately owned company to an integral part of the Sawai Group, a globally driven, publicly traded Japanese company,” said Rusty Field, president and CEO of Upsher-Smith.”
The NDC numbers for Klor-Con Powder (potassium chloride) for oral solution, 20 mEq are 0245-0360-30 for cartons of 30 packets and 0245-0360-01 for cartons of 100 packets.
Klor-Con is a registered trademark of Upsher-Smith Laboratories, LLC.
(Source: Upsher-Smith Laboratories, LLC)